Alderley Park-based YProTech lands life sciences fund investment

The Greater Manchester and Cheshire (GM&C) Life Sciences Fund has invested in Cheshire chemistry services company YProTech Ltd.

The firm will use its slice of the multi-million pound fund to commission a high-potency facility at its Alderley Park base, broadening its services and strengthening its sales and marketing capabilities.

The deal will see Tony Flinn, who is a venture partner with the fund’s manager Catapult Ventures, join the YProTech board as a non-executive director.

Tony, who founded chemistry services firm Onyx Scientific in 2000, said: “Chemistry services continue to grow strongly as the global pharmaceutical model changes to further outsource R&D.

“This is an area I know very well, and the new high-potency facility will enable YProTech to further expand its high-value, well-differentiated services.”

He added: “I’m excited to be joining the board of YProTech at this key time in its growth.”

YProTech was advised by Manchester-based investment firm Acceleris Capital during the transaction.

Tom Screen, the managing director of YProTech, commented: “I’m very pleased that Catapult Ventures recognised the value and growth potential of YProTech’s services and that Tony is joining the board with his extensive experience building a successful chemistry services business.

“I look forward to commissioning the new high-potency facility and growing YProTech to be a leader in high value chemistry services.”

The GM&C Life Sciences Fund makes initial investments of between £50k and £3m to support life science companies across Greater Manchester and Cheshire.

Since launching in September 2015, the fund has raised more than £30m for the region’s life sciences businesses, but that figure is expected to rise to £45.

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.